Clinical Trial Update: Sedation With Sevoflurane Versus Propofol in Patients With Acute Respiratory Distress Syndrome Caused by COVID19 Infection [Phase 4]

View source ↗

Summary

Phase 4 trial comparing sedation with sevoflurane versus propofol in COVID-19–associated acute respiratory distress syndrome has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Distress Syndrome

Drugs mentioned

• PROPOFOL (Propofol)
• Sevoflurane (Sevoflurane)

Snippet

Sponsor: Fundación para la Investigación del Hospital Clínico de Valencia | Conditions: Acute Respiratory Distress Syndrome, COVID19 Infection | Phase 4 | Status: TERMINATED